Projects per year
Fingerprint
Dive into the research topics where Klaus Podar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
JAK2 inhibitors: JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Kollmann, K. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.01.2022 → 30.09.2027
Project: Funded Research
-
APOG: ACCESS POINT Oncology
Podar, K. (PI), Stoiber-Sakaguchi, D. (CoPI), Pecherstorfer, M. (CoPI), Georg, P. (CoPI), Kieseberg, P. (CoPI), Fossati, P. (CoPI), Lütgendorf-Caucig, C. (CoPI) & Slade, D. (CoPI)
01.01.2020 → 31.12.2026
Project: Funded Research
-
STAT3: STAT3 isoforms in hematopoietic disorders
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Casanova, E. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.01.2021 → 31.12.2024
Project: Funded Research
-
PROTACs : Targeting Transcription factors for cancer therapy utilizing PROteolysis-TArgeting Chimera (PROTACs)
Podar, K. (PI)
01.08.2020 → 31.10.2022
Project: Forschungsimpulse › Research Time Out (RTO)
-
Biomarker: Biomarker- based therapeutic prevention of bone metastases in breast cancer. Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI), Podar, K. (CoI) & Wiesner, C. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.12.2019 → 31.12.2023
Project: Funded Research
Research output
-
A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia
Saladi, S. V., Garg, S., Weisberg, E. L., Case, A. E., Ni, W., Pareek, S., Podar, K., Salgia, R., Griffin, J. D., Stone, R. M. & Sattler, M., 17 Sept 2026, In: Molecular Therapy Oncology. 34, 3, p. 201262 201262.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Link opens in a new tab Citation (Scopus) -
Jahrestagung der American Society of Hematology (ASH) 2025 / Wichtige Studien im Überblick: Neu Diagnostiziertes Multiples Myelom
Podar, K., 02 Jan 2026, krebs:hilfe!.Research output: Book/Report › Report
-
PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells
Bragato, N., Dias, A. B., Ohradanova-Repic, A., Dupanovic, A., Horvat, F., Fischer, P., Appel, L.-M., Walch, L., Kleinwächter, A., Röhrer, A., Kerschbaum-Gruber, S., Barna, S., Fossati, P., Georg, D., Widder, J., Podar, K., Cohen, M. & Slade, D., 17 Sept 2026, In: Molecular Therapy Oncology. 34, 3, p. 201258 201258.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism
Oudaert, I., van den Broecke, L., Aksoy, O., Lind, J., Vallet, S., Van der Vreken, A., Ates, G., Massie, A., Maes, K., De Veirman, K., De Bruyne, E., Vanderkerken, K., Podar, K. & Menu, E., Feb 2026, In: Molecular Oncology. 20, 2, p. 447-463 17 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Link opens in a new tab Citation (Scopus) -
Treatment sequencing and emerging strategies in multiple myeloma—connecting the right nodes in the right order
Podar, K., Aug 2026, In: Memo - Magazine of European Medical Oncology.Research output: Journal article (peer-reviewed) › Letter/short communication
Prizes
Activities
- 1 Organising an event (Science to science)
-
1st Lower Austrian Conference on Cancer Research
Podar, K. (Organiser) & Vallet, S. (Co-Organiser)
13 Nov 2025Activity: Participating in/organising an event › Organising an event (Science to science)